PTT, a Thai state-owned SET-listed oil and gas company, agreed to invest in Lotus Pharmaceutical, a pharmaceuticals company, in a $50m deal. “This partnership is an important milestone in realizing our vision to establish Lotus as a global leader in generic oral oncology products. Lotus has secured partnerships with many of the leading pharmaceutical companies around the world to market and commercialize our products. The addition of Innobic (Asia) as a shareholder, will further support the long-term growth of Lotus in Asia and its mission to become a global leader in oral oncology,” Robert Wessman, Lotus Pharmaceuticals Chairman.